Cantor Fitzgerald started coverage on shares of GlycoMimetics (NASDAQ:GLYC – Free Report) in a research note published on ...

Researchers uncover new insights into the molecular mechanisms of ADAR1, a protein that regulates RNA-induced immune ...

A research team led by Rice University's Yang Gao has uncovered new insights into the molecular mechanisms of ADAR1, a protein that regulates ribonucleic acid (RNA) induced immune responses.

A research team led by Rice University's Yang Gao has uncovered new insights into the molecular mechanisms of ADAR1, a protein that regulates ...

A research team led by Rice's Yang Gao has uncovered new insights into the molecular mechanisms of ADAR1. ADAR1 converts adenosine to inosine in double-stranded RNA, a process essential for ...

Scientists have made a major discovery about ADAR1—a protein that controls RNA-induced immune responses—paving ...

Allakos Inc. (NASDAQ:ALLK – Get Free Report) was the recipient of a large decrease in short interest during the month of February. As of February 28th, there was short interest totalling 1,940,000 ...

That financing will be led by Cormorant Asset Management and will see the likes of Novo Holdings, ADAR1 Capital Management, Omega Funds and BioCapital Advisors, to name a few, scooping up the stock.

The planned PIPE is led by Cormorant and also includes investors like ADAR1 Capital Management, BC Capital and Wellington Management. The transaction proceeds will be used to fund BridgeBio ...

Welch Foundation, Cancer Prevention and Research Institute of Texas, NIH/National Institutes of Health ...